The growth of Viagra and its impact on the drug landscape presents a intricate question for shareholders. While the early sales data were astounding, the patent has ended, leading to a wave of copycat alternatives that are eroding profit. In addition, the sector is facing challenges related to demographic trends and changing healthcare policies,… Read More